ascendis pharma glp-1 receptor agonists weight management diabetes treatments GLP1 Agonists—Effects beyond Obesity and Emerging Role of GLP-1 Receptor

ascendis pharma glp-1 receptor agonists weight management diabetes treatments

ascendis pharma glp-1 receptor agonists weight management diabetes treatments GLP1 Agonists—Effects beyond Obesity and Emerging Role of GLP-1 Receptor

Name: ascendis pharma glp-1 receptor agonists weight management diabetes treatments GLP1 Agonists—Effects beyond Obesity and Emerging Role of GLP-1 Receptor
Brand: themeproject.nl
SKU: 32166251374
Price: 25.25 USD
Availability: InStock
Rating: 4.8316 (9 reviews)

SKU: 32166251374

4.8

USD25.25 USD71.25

Pay in 4 interest-free payments of $6.31 Learn more

Shipping Estimate
USA

USA

CAN

Ships within 48 hours · Estimated delivery Aug 15 - Aug 20

Description

Growth factor independence in vitro of primary melanoma cells from advanced but not early or intermediate lesions

The GLP-1RA liraglutide has also been approved for the treatment of obesity at a higher standard dose (3 mg once daily) compared to the standard dose used for T2D treatment (1.2 mg once daily) due to the results of the SCALE study program (37, 38)